Myeloid-derived suppressor cells: A new emerging player in endometriosis
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This paper explores the role of myeloid-derived suppressor cells in the development and progression of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a common gynecological disorder defined by the presence of endometrial tissue outside the uterus. This is commonly associated with chronic pelvic pain, infertility, and dysmenorrhea, which occurs in approximately 10% of women of reproductive age. Although the exact mechanism remains uncertain, it has been widely accepted to be an estrogen-dependent and inflammatory disease. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of immune cells with immunosuppressive capacity and non-immunological functions. They have been found to be aggressively involved in the pathologies of various disorders. In regards to tumors, the functions of MDSCs have been profoundly shown to inhibit tumor immune response and to promote angiogenesis, tumor metastasis, fibrosis, and epithelial-mesenchymal transition (EMT). In recent years, the elevation of MDSCs in endometriosis was reported by several studies that provoke the assumption that MDSCs might exert similar roles to promote the development of endometriosis. Such that, precision treatments targeting MDSCs might be a promising direction for future study. Herein, we will review the research progress of MDSCs in endometriosis and its potential relevance to the pathogenesis, progression, and therapeutics strategy of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Alteration of Myeloid-Derived Suppressor Cells, Chronic Inflammatory Cytokines, and Exosomal miRNA Contribute to the Peritoneal Immune Disorder of Patients With Endometriosis via openalex
- CD33<sup>+</sup>CD14<sup>+</sup>CD11b<sup>+</sup>HLA‐DR<sup>−</sup> monocytic myeloid‐derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis via openalex
- CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
- Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis via openalex
- Decreased Natural Killer Cell Activity in Women with Endometriosis via openalex
- Deficient cellular immunity in endometriosis via openalex
- Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets via openalex
- Differential Levels of Regulatory T Cells and T-Helper-17 Cells in Women With Early and Advanced Endometriosis via openalex
- EGFR‐mediated matrix metalloproteinase‐7 up‐regulation promotes epithelial‐mesenchymal transition <i>via</i> ERK1‐AP1 axis during ovarian endometriosis progression via openalex
- Endometrial epithelial–mesenchymal transition (EMT) by menstruation-related inflammatory factors during hypoxia via openalex
- Endometriosis and autologous lymphocyte activation by endometrial cells. Are lymphocytes or endometrial cell defects responsible? via openalex
- Endometriosis and possible inflammation markers via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Epithelial–Mesenchymal Transition in Endometriosis—When Does It Happen? via openalex
- Epithelial-to-mesenchymal transition contributes to the downregulation of progesterone receptor expression in endometriosis lesions via openalex
- Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis via openalex
- Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP‐α in peritoneal macrophages via openalex
- Evaluation of M1 and M2 macrophages in ovarian endometriomas from women affected by endometriosis at different stages of the disease via openalex
- Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study via openalex
- Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women with Endometriosis via openalex
- Expressions of natural cytotoxicity receptor, NKG2D and NKG2D ligands in endometriosis via openalex
- Identification of differentially expressed proteins associated with recurrence in ovarian endometriotic cysts via openalex
- IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis via openalex
- Immunology of endometriosis via openalex
- Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: A possible role for PCBs and DDE via openalex
- Increased frequency of human leukocyte antigen–E inhibitory receptor CD94/NKG2A–expressing peritoneal natural killer cells in patients with endometriosis via openalex
- Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis via openalex
- Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis via openalex
- Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis via openalex
- Interleukin‐22 secreted by ectopic endometrial stromal cells and natural killer cells promotes the recruitment of macrophages through promoting CCL2 secretion via openalex
- Interleukin (IL)-17A Stimulates IL-8 Secretion, Cyclooxygensase-2 Expression, and Cell Proliferation of Endometriotic Stromal Cells via openalex
- In vitro lymphocyte activity in women with endometriosis—an altered immune response? via openalex
- Killer Inhibitory Receptor CD158a Overexpression Among Natural Killer Cells in Women With Endometriosis is Undiminished by Laparoscopic Surgery and Gonadotropin Releasing Hormone Agonist Treatment* via openalex
- Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis via openalex
- Lymphokine-Activated Killer Activity in Women with Endometriosis via openalex
- MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target via openalex
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- Natural killer activity in stage III and IV endometriosis via openalex
- Natural Killer Cells: Key Players in Endometriosis via openalex
- New developments in the medical treatment of endometriosis via openalex
- NK Cells as Potential Targets for Immunotherapy in Endometriosis via openalex
- Oestrogen induces epithelial‐mesenchymal transition in endometriosis via circ_0004712/miR‐148a‐3p sponge function via openalex
- Pelvic endometriosis and natural killer cell immunity via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal fluid and plasma levels of human macrophage colony- stimulating factor in relation to peritoneal fluid macrophage content via openalex
- Peritoneal fluid concentrations of interleukin‐17 correlate with the severity of endometriosis and infertility of this disorder via openalex
- Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis via openalex
- Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis via openalex
- Pregnancy outcomes in women with endometriosis: a national record linkage study via openalex
- Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis via openalex
- Reduction of myeloid derived suppressor cells by inhibiting Notch pathway prevents the progression of endometriosis in mice model via openalex
- Reprint of: Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway via openalex
- Single-cell transcriptomic analysis of endometriosis provides insights into fibroblast fates and immune cell heterogeneity via openalex
- Stem Cell Factor (SCF) Concentrations in Peritoneal Fluid of Women with or without Endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear via openalex
- The establishment of a mouse model of deep endometriosis via openalex
- The link between immunity, autoimmunity and endometriosis: a literature update via openalex
- The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target via openalex
- The Role of Peritoneal Macrophages in Endometriosis via openalex
- Time to redefine endometriosis including its pro-fibrotic nature via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- “What do we know about regulatory T cells and endometriosis? A systematic review” via openalex
- World Endometriosis Society consensus on the classification of endometriosis via openalex
- W2230023079 via openalex
- W2260656780 via openalex
- W2304854632 via openalex
- W2079361633 via openalex
- W2073606915 via openalex
- W2059688175 via openalex
- W2469469957 via openalex
- W2471500324 via openalex
- W2488076079 via openalex
- W2560559257 via openalex
- W2577696913 via openalex
- W2055983169 via openalex
- W2055965331 via openalex
- W2051657147 via openalex
- W2732191214 via openalex
- W2732589699 via openalex
- W2743999379 via openalex
- W2782485041 via openalex
- W2783873937 via openalex
- W2030753263 via openalex
- W2021268612 via openalex
- W2016431623 via openalex
- W2793492950 via openalex
- W2800345927 via openalex
- W2803115351 via openalex
- W2884952568 via openalex
- W2888367509 via openalex
- W2898271922 via openalex
- W2015919529 via openalex
- W2012405690 via openalex
- W2918589641 via openalex
- W2003603044 via openalex
- W2921373828 via openalex
Cited by (6)
- The lactate-myeloid-derived suppressor cells axis in endometriosis from molecular reprogramming to translational therapies: A review article 2026
- The microbiome–inflammasome axis in endometriosis-associated chronic pelvic pain: mechanisms and therapeutic opportunities from an immunological perspective 2026
- Molecular links in endometriosis pathogenesis as targets for diagnosis and targeted therapy: a review 2025
- Lactate-mediated immune suppression and MDSC expansion in endometriosis: Mechanisms and nanoparticle-targeted therapies 2025
- Current Understanding of Endometriosis Pathophysiology and Future Perspectives 2025
- Determination of Serum Arginase-1 Concentrations and Serum Arginase Activity for the Non-Invasive Diagnosis of Endometriosis 2024
Source provenance
- europepmc
- last seen: 2026-09-25T06:10:54.854274+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-25T06:10:16.197049+00:00
- unpaywall
- last seen: 2026-09-25T06:33:09.130943+00:00
License: CC0
· commercial use OK